Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Maul, J-T; Navarini, A A; Sommer, R; Anzengruber, F; Sorbe, C; Mrowietz, U; Drach, M; Blome, C; Boehncke, W-H; Thaci, D; Reich, K; von Kiedrowski, R; Körber, A; Yawalkar, N; Mainetti, C; Laffitte, E; Streit, M; Rustenbach, S; Conrad, C; Borradori, L; Gilliet, M; Cozzio, A; Itin, P; Häusermann, P; French, L E; Radtke, M A; Augustin, M (2019). Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice. Journal of the European Academy of Dermatology and Venerology, 33(4):700-708.

Reich, K; Pinter, A; Lacour, J P; Ferrandiz, C; Micali, G; French, L E; Lomaga, M; Dutronc, Y; Henneges, C; Wilhelm, S; Hartz, S; Paul, C (2017). Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. British Journal of Dermatology, 177(4):1014-1023.

Dirschka, T; Radny, P; Dominicus, R; Mensing, H; Brüning, H; Jenne, L; Karl, L; Sebastian, M; Oster-Schmidt, C; Klövekorn, W; Reinhold, U; Tanner, M; Gröne, D; Deichmann, M; Simon, M; Hübinger, F; Hofbauer, G; Krähn-Senftleben, G; Borrosch, F; Reich, K; Berking, C; Wolf, P; Lehmann, P; Moers-Carpi, M; Hönigsmann, H; Wernicke-Panten, K; Helwig, C; Foguet, M; Schmitz, B; Lübbert, H; Szeimies, R M (2012). Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. British Journal of Dermatology, 166(1):137-146.

Distler, M; Distler, J; Ciurea, A; Kyburz, D; Müller-Ladner, U; Reich, K; Distler, O (2006). Evidenzbasierte Therapie des Raynaud-Syndroms. Zeitschrift für Rheumatologie, 65(4):285-289.

This list was generated on Sat Apr 20 19:32:37 2019 CEST.